Author
Listed:
- Jesper D. Gunst
(Aarhus University Hospital
Aarhus University)
- Jesal Gohil
(Imperial College NIHR BRC)
- Johanthan Z. Li
(Harvard Medical School)
- Ronald J. Bosch
(Harvard T.H. Chan School of Public Health)
- Andrea White, Catherine Seamon
(National Institutes of Health)
- Tae-Wook Chun
(National Institutes of Health)
- Beatriz Mothe
(IrsiCaixa Immunopathology Research Institute
Hospital Universitari Germans Trias I Pujol
Instituto de Salud Carlos III
University of Vic – Central University of Catalonia (UVic-UCC))
- Kathleen Gittens
(National Institutes of Health)
- Lauren Praiss
(National Institutes of Health)
- Marie-Angélique Scheerder
(Ghent University Hospital)
- Linos Vandekerckhove
(Ghent University)
- Kevin Escandón
(University of Minnesota
University of Minnesota)
- Ann Thorkelson
(University of Minnesota)
- Timothy Schacker
(University of Minnesota
University of Minnesota)
- Devi SenGupta
(Inc)
- Christian Brander
(IrsiCaixa Immunopathology Research Institute
Instituto de Salud Carlos III
University of Vic – Central University of Catalonia (UVic-UCC)
AELIX Therapeutics)
- Emmanouil Papasavvas
(The Wistar Institute)
- Luis J. Montaner
(The Wistar Institute)
- Javier Martinez-Picado
(IrsiCaixa Immunopathology Research Institute
Instituto de Salud Carlos III
University of Vic – Central University of Catalonia (UVic-UCC)
Catalan Institution for Research and Advanced Studies (ICREA))
- Ruxandra Calin
(Tenon Hospital, Sorbonne University, AP-HP)
- Antonella Castagna
(Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute
Vita-Salute San Raffaele University)
- Camilla Muccini
(Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute)
- Wesley de Jong
(Erasmus MC)
- Lorna Leal
(Hospital Clínic Barcelona
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Universitat de Barcelona)
- Felipe Garcia
(Hospital Clínic Barcelona
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Universitat de Barcelona)
- Rob A. Gruters
(Erasmus MC)
- Timothy Tipoe
(University of Oxford, UK and NIHR Oxford Biomedical Research Centre)
- John Frater
(University of Oxford, UK and NIHR Oxford Biomedical Research Centre)
- Ole S. Søgaard
(Aarhus University Hospital
Aarhus University)
- Sarah Fidler
(Imperial College NIHR BRC)
Abstract
The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challenges. To understand viral dynamics and rates of post-treatment control (PTC) after ATI among PWH receiving either placebo or no intervention, we undertook an individual-participant data meta-analysis. In total, 24 eligible prospective studies with 382 individuals with ≥5 plasma HIV RNA viral loads (pVLs) within the first 84 days post-ATI were included. Early-ART was defined as ART initiation within 6 months of HIV acquisition; others were classified as late-ART or unknown. Median age was 42 years, 91% male, 75% white, 45% received early-ART. Median time to pVL >50, >400, and >10,000 copies/mL was 16 days (interquartile range [IQR]:13–25), 21 (IQR:15–28), and 32 (IQR:20–35), respectively. PTC defined as pVL
Suggested Citation
Jesper D. Gunst & Jesal Gohil & Johanthan Z. Li & Ronald J. Bosch & Andrea White, Catherine Seamon & Tae-Wook Chun & Beatriz Mothe & Kathleen Gittens & Lauren Praiss & Marie-Angélique Scheerder & Lino, 2025.
"Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies,"
Nature Communications, Nature, vol. 16(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56116-1
DOI: 10.1038/s41467-025-56116-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56116-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.